Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |